Market News AIOpen the app

TOVX stock news · Theriva Biologics, Inc.

Stories about Theriva Biologics, Inc. (TOVX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for TOVX

Follow Theriva Biologics, Inc. (TOVX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TOVX
Free on the App Store and Google Play, or on the web.
  1. Nov 20, 2026, 4:38 PM ET · Market

    Theriva Biologics will do a reverse stock split on December 1, 2026, to meet NYSE American rules.

    Neutral

    Theriva approved a 1-for-30 reverse stock split, set to take effect December 1, 2026. It aims to meet exchange share-price rules but does not change the company's business outlook.

  2. Nov 20, 2026, 4:37 PM ET · Market

    Theriva Biologics will do a 1-for-30 reverse stock split starting December 1, 2026, to meet NYSE rules.

    Neutral

    Theriva Biologics will combine 30 shares into 1, reducing outstanding shares from 45,892,668 to about 1,529,756. The move aims to meet exchange price rules but generally leaves owners' proportional stakes unchanged.